For the quarter ending 2025-12-31.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Research and development | 1,118,649 | 993,066 | 1,387,275.25* | |
| General and administrative | 1,114,525 | 803,619 | 1,010,636* | |
| Total operating expenses | 2,233,174 | 1,796,685 | 2,397,911.25 | |
| Loss from operations | -2,233,174 | -1,796,685 | -2,397,911.25* | |
| Interest income | 12,455 | 11,627 | 31,207* | |
| Interest expense | - | - | 37.25* | |
| Other income, net | 12,455 | 11,627 | 31,169.75* | |
| Net loss | -2,220,719 | -1,785,058 | -2,366,741.5 | |
| Basic EPS | -0.11 | -0.1 | -0.157 | |
| Diluted EPS | -0.11 | -0.1 | -0.157 | |
| Basic Average Shares | 19,850,080 | 17,082,425 | 15,116,548 | |
| Diluted Average Shares | 19,850,080 | 17,082,425 | 15,116,548 | |
NANOVIRICIDES, INC. (NNVC)
NANOVIRICIDES, INC. (NNVC)